Related Experiment Video

Updated: Jul 9, 2026

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

TPO-independent megakaryocytopoiesis

Cuiling Zheng1, Renchi Yang, Zhongchao Han

  • 1State Key Laboratory of Experimental Hematology, Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, PR China.

Critical Reviews in Oncology/Hematology
|December 21, 2007
PubMed

Insights

Thrombopoietin (TPO) regulates platelet production, but other TPO-independent pathways also control megakaryocytopoiesis. Understanding these pathways is crucial for treating platelet disorders.

Area of Science:

  • Hematology
  • Cell Biology
  • Developmental Biology

Background:

  • Megakaryocytopoiesis, the process of platelet production, is regulated by a complex network of growth factors.
  • Thrombopoietin (TPO) is the primary studied regulator of megakaryocytes (MKs).
  • TPO-independent pathways significantly influence megakaryocytopoiesis, suggesting a multifaceted regulatory system.

Purpose of the Study:

  • To elucidate the TPO-independent regulatory system of megakaryocytopoiesis.
  • To identify key signaling pathways involved in TPO-independent megakaryocyte development.
  • To explore the therapeutic potential of targeting TPO-independent pathways for platelet disorders.

Main Methods:

  • Review and synthesis of existing literature on megakaryocytopoiesis.
  • Identification and categorization of TPO-independent signaling pathways.
  • Analysis of the roles of gp 130, Notch, NMDA receptor, and SDF-1/FGF-4 pathways.

Main Results:

  • Four major TPO-independent signaling pathways identified: gp 130-dependent, Notch, NMDA receptor-mediated, and SDF-1/FGF-4.
  • These pathways operate independently of TPO signaling.
  • The complete regulatory network includes these four pathways and potentially unknown signaling mechanisms.

Conclusions:

  • The TPO-independent regulatory system is critical for understanding megakaryocytopoiesis.
  • This system offers novel therapeutic targets for thrombocytopenia and thrombocythemia.
  • Further research into TPO-independent pathways can advance treatments for abnormal platelet production disorders.

More Related Videos

Isolation of Mouse Megakaryocyte Progenitors10:30

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...